Cargando…
Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA
Over the past decade, the detection and analysis of liquid biopsy biomarkers such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have advanced significantly. They have received recognition for their clinical usefulness in detecting cancer at an early stage, monitoring disease, a...
Autores principales: | Yaghoubi Naei, Vahid, Bordhan, Pritam, Mirakhorli, Fatemeh, Khorrami, Motahare, Shrestha, Jesus, Nazari, Hojjatollah, Kulasinghe, Arutha, Ebrahimi Warkiani, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486235/ https://www.ncbi.nlm.nih.gov/pubmed/37692363 http://dx.doi.org/10.1177/17588359231192401 |
Ejemplares similares
-
The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
por: Kapeleris, Joanna, et al.
Publicado: (2018) -
The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
por: Kulasinghe, Arutha, et al.
Publicado: (2018) -
ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress
por: Neumann, Martin H.D., et al.
Publicado: (2018) -
Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
por: Lim, Minji, et al.
Publicado: (2018) -
Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets
por: Kulasinghe, Arutha, et al.
Publicado: (2019)